Citigroup Initiates Coverage On IDEXX Laboratories with Neutral Rating, Announces Price Target of $650

Benzinga Newsdesk www.benzinga.com Neutral 78.4%

Neg 0% Neu 78.4% Pos 0%

Citigroup analyst Daniel Grosslight initiates coverage on IDEXX Laboratories (NASDAQ:IDXX) with a Neutral rating and announces Price Target of $650.